Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 7,251–7,275 of 7,816 matching trials · page 291 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Deep Brain Stimulation of the Globus Pallidus in Huntington's Disease NCT00902889 Stimulation; Stimulation Runs in: Germany · 1 site |
PHASE1 other |
COMPLETED | 6 | Heinrich-Heine University, Duesseldorf OTHER |
2012-09-11 |
|
A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease NCT00862940 Memantine; Placebo |
PHASE4 symptomatic-cholinergic |
COMPLETED | 277 | H. Lundbeck A/S INDUSTRY |
2012-09-03 |
|
Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease NCT01482013 HPP854; Placebo Runs in: United States · 3 sites |
PHASE1 other |
TERMINATED | 7 | High Point Pharmaceuticals, LLC. INDUSTRY |
2012-08-30 |
|
Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease NCT00857233 Memantine Runs in: Canada · 33 sites |
PHASE3 symptomatic-cholinergic |
TERMINATED | 297 | H. Lundbeck A/S INDUSTRY |
2012-08-29 |
|
Exploratory and Safety Study of [F-18]W372 NCT00954369 [F-18]W372 Runs in: United States · 1 site |
EARLY_PHASE1 other |
COMPLETED | 24 | Siemens Molecular Imaging INDUSTRY |
2012-08-22 |
|
Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD) NCT00212316 sodium phenylbutyrate Runs in: United States · 8 sites |
PHASE2 other |
COMPLETED | 60 | University of Rochester OTHER |
2012-08-15 |
|
A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET) NCT01503944 18F-AV-133; 18F-AV-45 Runs in: United States · 2 sites |
PHASE1|PHASE2 other |
COMPLETED | 30 | Avid Radiopharmaceuticals INDUSTRY |
2012-08-14 |
|
Video-Based Coping Skills Training for Caregivers NCT00396825 Video-based coping skills training with telephone coaching Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 116 | Williams LifeSkills INDUSTRY |
2012-08-13 |
|
Thalidomide for Patients With Mild to Moderate Alzheimer's Disease NCT01094340 Thalidomide Runs in: United States · 1 site |
PHASE2|PHASE3 other |
UNKNOWN | 20 | Banner Health OTHER |
2012-08-08 |
|
Haloperidol vs Olanzapine for the Management of ICU Delirium NCT00833300 Haloperidol; Olanzapine Runs in: Canada · 2 sites |
NA other |
TERMINATED | 200 | Richard Hall OTHER |
2012-08-03 |
|
Cognitive Assessment Battery (CAB) Beta Study NCT01290861 Runs in: Australia; Canada; United Kingdom; United States · 20 sites |
NA other |
COMPLETED | 255 | CHDI Foundation, Inc. OTHER |
2012-08-03 |
|
Alzheimer's in Long-Term Care--Treatment for Agitation NCT00161473 prazosin; placebo (inert substance) Runs in: United States · 1 site |
NA other |
COMPLETED | 24 | University of Washington OTHER |
2012-08-02 |
|
Delirium Recall in Advanced Cancer Patients NCT00493714 Questionnaire Runs in: United States · 1 site |
NA other |
COMPLETED | 200 | M.D. Anderson Cancer Center OTHER |
2012-07-30 |
|
Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals NCT00855868 florbetapir F 18; [11C]-PIB Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 28 | Avid Radiopharmaceuticals INDUSTRY |
2012-07-26 |
|
Prospective Randomised Controlled Trial of Delirium Management by Geriatric Medicine Versus General Medicine NCT01650896 Geriatric assessment review Runs in: Australia · 1 site |
NA other |
UNKNOWN | 250 | Central Coast Local Health District OTHER |
2012-07-26 |
|
Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study) NCT00794625 Valproate; Risperidone; Placebo; Stimulant medication; Behavioral f... Runs in: United States · 3 sites |
PHASE4 other |
UNKNOWN | 270 | Joseph Blader NIH |
2012-07-16 |
|
Cognitive Activation Therapy for MCI: A Randomized Control Study NCT01641328 Cogntive Activation Training; Waitlist Control / Home-based training Runs in: Canada · 1 site |
PHASE1 other |
UNKNOWN | 30 | Rotman Research Institute at Baycrest OTHER |
2012-07-16 |
|
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center NCT01465360 Runs in: United States · 3 sites |
NA other |
COMPLETED | 160 | Exonhit INDUSTRY |
2012-07-06 |
|
Effects of Involvement in a Group-based Creative Expression Program on Psychotropic Drug Use in Persons With Dementia NCT01382693 TimeSlips; Standard care activity program Runs in: United States · 1 site |
NA other |
COMPLETED | 20 | Milton S. Hershey Medical Center OTHER |
2012-07-04 |
|
Subclinical Hypothyroidism and Mind in the Elderly NCT00921050 levothyroxine sodium; excipient without levothyroxine (placebo) Runs in: Mexico · 2 sites |
PHASE2|PHASE3 other |
COMPLETED | 70 | Universidad Autonoma de Nuevo Leon OTHER |
2012-06-28 |
|
Chronic Electrical Stimulation of Hypothalamus/Fornix in Alzheimer's Disease NCT00888056 Bilateral chronic electrical stimulation of the hypothalamus/fornix Runs in: France · 1 site |
PHASE1|PHASE2 other |
UNKNOWN | 5 | Centre Hospitalier Universitaire de Nice OTHER |
2012-06-27 |
|
Ubiquitous Spaced Retrieval-based Memory Advancement and Rehabilitation Training NCT01628653 U-SMART Runs in: South Korea · 1 site |
PHASE1 other |
COMPLETED | 10 | Seoul National University Bundang Hospital OTHER |
2012-06-27 |
|
Evaluation of a Diet in Patients With Senile Dementia NCT01192529 Supressi. T-Diet plus Range; High Protein. T-Diet plus Range Runs in: Spain · 3 sites |
NA other |
UNKNOWN | 184 | Vegenat, S.A. INDUSTRY |
2012-06-22 |
|
Establish Taiwan Alzheimer's Disease Neuroimaging Initiative - a Three-year Pilot Study NCT01624389 F18-AV45 Runs in: Taiwan · 1 site |
NA other |
UNKNOWN | 200 | Chang Gung Memorial Hospital OTHER |
2012-06-20 |
|
A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers NCT01565330 florbetapir F 18 Runs in: United States · 3 sites |
PHASE1 other |
COMPLETED | 20 | Avid Radiopharmaceuticals INDUSTRY |
2012-06-18 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial